Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

CTD-O 12.5/40 Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Olmesartan Medoxomil (40mg) + Chlorthalidone (12.5mg)

Overview CTD-O 12.5/40 Tablet

The dual-component CTD-O 12.5/40 Tablet effectively manages hypertension through a synergistic mechanism. Untreated hypertension significantly increases the risk of serious complications, including stroke, heart attack, and kidney failure. This medication can be administered with or without food, with dosage tailored to individual response and health status. Consistent daily dosing is crucial for optimal therapeutic effect; continue treatment as directed by your physician. Its diuretic component promotes increased urination; therefore, avoid nighttime administration within four hours of sleep. Regular use is vital, even during asymptomatic periods, as hypertension often presents subtly. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects include dizziness, fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is an expected diuretic effect, contributing to blood pressure control, not an adverse reaction. While less frequent, other side effects are possible. Consult the patient information leaflet and report persistent or bothersome side effects to your doctor; dosage adjustment or alternative therapies may be considered. Avoid use during pregnancy, and inform your physician of any pre-existing kidney, liver, cardiac, or diabetic conditions before initiating treatment. Alcohol consumption may potentiate hypotension and increase the likelihood of side effects.

Primary Ingredients of CTD-O 12.5/40 Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of CTD-O 12.5/40 Tablet

Elevated arterial blood pressure

Major Benefits of CTD-O 12.5/40 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-O 12.5/40 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.

Common Side effects of CTD-O 12.5/40 Tablet:

  • Nausea
  • Taste change
  • Diarrhea
  • Upset stomach
  • Weakness
  • Headache
  • Increased blood uric acid
  • Dizziness
  • Increased blood lipid level
  • Electrolyte imbalance
  • Decreased blood pressure
  • Urinary tract infection
  • Renal dysfunction
  • Sore throat
  • Abnormal liver function tests
  • Increased potassium level in blood

How to use CTD-O 12.5/40 Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-O 12.5/40 Tablet can be consumed with or without food, though consistent timing is recommended.

How CTD-O 12.5/40 Tablet works:

Each CTD-O 12.5/40 Tablet contains a dual-drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of CTD-O 12.5/40 tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of CTD-O 12.5/40 Tablet is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of CTD-O 12.5/40 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking a CTD-O 12.5/40 Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with severe renal impairment should exercise caution when using CTD-O 12.5/40 Tablet, as dose modification may be necessary. Physician consultation is advised; the medication is generally unsuitable for such individuals.

LiverLiverCAUTION

Patients with hepatic impairment should use CTD-O 12.5/40 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. CTD-O 12.5/40 Tablet is contraindicated in individuals with severe liver disease.

What if you forget to take CTD-O 12.5/40 Tablet :

Should you forget to take your CTD-O 12.5/40 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About CTD-O 12.5/40 Tablet

LabelValue
Developing Habits No.
Treatment Category Heart

FAQs on CTD-O 12.5/40 Tablet

Expect a noticeable blood pressure reduction within two weeks of starting CTD-O 12.5/40 Tablet, though optimal results may take up to eight weeks. Consult your doctor with any concerns, but do not discontinue use without their advice.
To minimize dizziness, your doctor may recommend taking your first CTD-O 12.5/40 Tablet dose before bed. Subsequent doses can be taken at any time of day, but consistency is key—take it at the same time daily. If uncertain, consult your doctor.
Dizziness is a possible side effect of CTD-O 12.5/40 Tablets, particularly when standing up quickly after lying down or sitting. To minimize this risk, rise slowly from a lying or seated position.
To maximize the benefits of CTD-O 12.5/40 Tablet and maintain your health, adopt a healthy lifestyle. This includes a low-sodium diet, stress management techniques (yoga, meditation, hobbies), sufficient sleep, and quitting smoking and alcohol. Regular exercise and a balanced diet rich in whole grains, fruits, vegetables, and low-fat options are also crucial. Consult your doctor for personalized guidance.
CTD-O 12.5/40 Tablet is not associated with weight gain. While rare, significant weight loss due to chronic diarrhea is a possible side effect. If diarrhea develops during treatment and other causes are ruled out, your doctor may recommend stopping the medication and switching to an alternative.
CTD-O 12.5/40 Tablet can cause serious side effects such as skin rash or itching, joint pain, rapid heartbeat, and shortness of breath or chest tightness. Muscle aches, tenderness, or weakness (unrelated to exercise), and swelling in the hands, feet, or ankles are also possible. High potassium levels, indicated by nausea, diarrhea, muscle weakness, and irregular heartbeat, may also occur. Seek immediate medical attention if you experience any of these symptoms.
Certain blood pressure medications, such as diuretics like hydrochlorothiazide, can sometimes cause erectile dysfunction. Conversely, other blood pressure drugs may improve erectile function. Discuss any concerns or changes with your doctor. Currently, there's no conclusive evidence that CTD-O 12.5/40 Tablet affects male or female fertility.
You may need to take CTD-O 12.5/40 tablets for life, as it manages, but doesn't cure, high blood pressure. Continue taking it even with well-controlled pressure. While generally safe for long-term use, it can sometimes affect kidney function. To monitor this, your doctor may order regular blood tests (urea, creatinine, and potassium) to assess kidney health.
Discontinue CTD-O 12.5/40 Tablet 24 hours prior to any surgery, as it may interact with anesthetics, causing excessive blood pressure reduction. Inform your surgeon if you are taking this medication, especially before general anesthesia.
CTD-O 12.5/40 Tablet
238
MRP 289
17% off